Evidence map›Paper›PMID 23908475›Full record

ArticleThe Journal of infectious diseases2013

Early immunologic failure is associated with early mortality among advanced HIV-infected adults initiating antiretroviral therapy with active tuberculosis.

Shruthi Ravimohan, Neo Tamuhla, Andrew P Steenhoff, Rona Letlhogile, Didimalang Kgomotso Makutu, Kebatshabile Nfanyana, Tumelo Rantleru, Ann Tierney, Kelebogile Nkakana, Adam B Schwartz and 6 more

Abstract read
In one paragraph

Article in The Journal of infectious diseases, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Lung Injury on Antiretroviral Therapy in Adults With Human Immunodeficiency Virus/Tuberculosis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020
    Article
  8. Review
  9. Observational
  10. Factors associated with mortality in persons co-infected with tuberculosis and HIV in Suriname: a retrospective cohort study.Revista panamericana de salud publica = Pan American journal of public health · 2019
    Article
  11. Common Variation inOpen forum infectious diseases · 2018
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Observational
  17. Article
  18. Article
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Shruthi RavimohanDepartment of Medicine, Division of Infectious Diseases.
Neo Tamuhla
Andrew P Steenhoff
Rona Letlhogile
Didimalang Kgomotso Makutu
Kebatshabile Nfanyana
Tumelo Rantleru
Ann Tierney
Kelebogile Nkakana
Adam B Schwartz
Robert Gross
Rob Roy Macgregor
Scarlett L Bellamy
Ian Frank
Drew Weissman
Gregory P Bisson

Funding

Virus & Reservoirs CoreP30AI045008 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI ROBERT GROSS · 1999 to 2026
$78.6M
Immunology and Outcomes after HAART in HIV/TB CoinfectionR01AI080337 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI BISSON, GREGORY P. · 2009 to 2013
$3.5M
NIAID NIH HHS 5R01AI080337NIAID NIH HHS AI045008NIAID NIH HHS P30 AI045008NIAID NIH HHS R01 AI080337
6 · The paper itself

Abstract

backgroundThe relationship between antiretroviral therapy (ART) response and early mortality after ART initiation is unknown. We hypothesized that early mortality is associated with decreased early immunologic response to ART.

methodsWe prospectively determined the association between changes in plasma human immunodeficiency virus type 1 (HIV-1) RNA and CD4(+) T-cell counts (CD4 count) after 4 weeks of ART and early mortality in adults with pulmonary tuberculosis and pre-ART CD4 counts ≤ 125 cells/µL. Purified protein derivative (PPD)-specific immune recovery was determined by interferon-γ enzyme-linked immunosorbent spot assays. Levels of interleukin 6, C-reactive protein, and soluble CD14 were assessed. Patients with CD4 count and viral load values at baseline and week 4 were analyzed using multiple logistic regression.

resultsEarly immunologic response, but not pre-ART CD4 counts or virologic response, was related to early mortality (8 [interquartile range {IQR}, -18 to 43] vs 68 [IQR, 24-131] cells/µL, P = .002). In a logistic regression model, every 20 cells/µL increase in the CD4 count from baseline to week 4 was independently associated with a 40% reduction in the odds of death (odds ratio, 0.59 [95% confidence interval, .41-.87]). PPD-specific immune recovery was lower, whereas levels of immune activation were higher, among deaths.

conclusionsEarly immunologic failure despite virologic suppression is associated with early mortality after ART initiation in advanced HIV/tuberculosis.

Indexed as

Antiretroviral Therapy, Highly ActiveAdultBotswanaCD4 Lymphocyte CountCohort StudiesC-Reactive ProteinFemaleHIV-1HIV InfectionsHumansInterferon-gammaInterleukin-6Logistic ModelsMaleMiddle AgedMycobacterium tuberculosisC-Reactive ProteinIL6 protein, humanInterferon-gammaInterleukin-6RNA, Viralantiretroviral therapyCD4 countsearly mortalityHIV/AIDSimmune activationimmune recoverypathogen-specific immune recoverysub-Saharan Africatuberculosis

Identifiers

PMID23908475
PMCPMC3814836

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.